InMode to Participate in Upcoming Investor Conferences
InMode (NASDAQ:INMD), a leading global provider of innovative medical technologies, has announced its participation in two upcoming investor conferences in August 2025. The company will attend the 10th Annual Needham Virtual MedTech & Diagnostics Conference on August 11, where CEO Moshe Mizrahy will conduct virtual one-on-one meetings.
Additionally, CFO Yair Malca will participate in the Canaccord 45th Annual Global Growth Conference in Boston on August 12 at 2:30 pm ET, featuring a fireside chat moderated by Caitlin Cronin and investor meetings. A live webcast of the presentation will be available.
InMode (NASDAQ:INMD), un leader globale nelle tecnologie mediche innovative, ha annunciato la sua partecipazione a due conferenze per investitori previste per agosto 2025. L'azienda sar脿 presente al 10掳 Annuale Needham Virtual MedTech & Diagnostics Conference l'11 agosto, dove il CEO Moshe Mizrahy terr脿 incontri virtuali individuali.
Inoltre, il CFO Yair Malca parteciper脿 al 45掳 Canaccord Annual Global Growth Conference a Boston il 12 agosto alle 14:30 ET, con una tavola rotonda moderata da Caitlin Cronin e incontri con investitori. La presentazione sar脿 trasmessa in diretta streaming.
InMode (NASDAQ:INMD), un proveedor global l铆der en tecnolog铆as m茅dicas innovadoras, ha anunciado su participaci贸n en dos pr贸ximas conferencias para inversores en agosto de 2025. La compa帽铆a asistir谩 a la 10陋 Conferencia Anual Virtual Needham MedTech & Diagnostics el 11 de agosto, donde el CEO Moshe Mizrahy realizar谩 reuniones virtuales individuales.
Adem谩s, el CFO Yair Malca participar谩 en la 45陋 Conferencia Anual Global de Crecimiento Canaccord en Boston el 12 de agosto a las 2:30 pm ET, con una charla informal moderada por Caitlin Cronin y reuniones con inversores. Habr谩 una transmisi贸n en vivo de la presentaci贸n.
InMode (NASDAQ:INMD)電� 順侅嫚鞝侅澑 鞚橂 旮办垹鞚� 靹犽弰頃橂姅 旮�搿滊矊 旮办梾鞙茧, 2025雲� 8鞗� 鞓堨爼霅� 霊� 臧滌潣 韴瀽鞛� 旎嵓霟办姢鞐� 彀戈皜頃� 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 8鞗� 11鞚� 鞝�10須� 鞐半 雼堧摐頄� 臧�靸� MedTech & Diagnostics 旎嵓霟办姢鞐� 彀胳劃頃橂┌, CEO 氇叞 氙胳霛柬瀳臧� 1:1 臧�靸� 氙疙寘鞚� 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
霕愴暅 CFO 鞎检澊毳� 毵愳勾電� 8鞗� 12鞚� 鞓ろ泟 2鞁� 30攵�(霃欕秬鞁滉皠) 氤挫姢韯挫棎靹� 鞐措Μ電� 旌愲倶旖旊摐 鞝�45須� 鞐半 旮�搿滊矊 靹膘灔 旎嵓霟办姢鞐� 彀胳棳頃橃棳 旒�鞚错媭毽� 韥雼岇澊 歆勴枆頃橂姅 雽�雼搓臣 韴瀽鞛� 氙疙寘鞐� 彀胳劃頃╇媹雼�. 頂勲爤鞝犿厡鞚挫厴鞚� 鞁れ嫓臧� 鞗轨簮鞀ろ姼搿� 鞝滉车霅╇媹雼�.
InMode (NASDAQ:INMD), un fournisseur mondial de premier plan en technologies m茅dicales innovantes, a annonc茅 sa participation 脿 deux conf茅rences pour investisseurs pr茅vues en ao没t 2025. La soci茅t茅 assistera 脿 la 10e conf茅rence annuelle virtuelle Needham MedTech & Diagnostics le 11 ao没t, o霉 le PDG Moshe Mizrahy tiendra des r茅unions virtuelles individuelles.
De plus, le CFO Yair Malca participera 脿 la 45e conf茅rence annuelle Canaccord Global Growth 脿 Boston le 12 ao没t 脿 14h30 ET, avec une discussion informelle anim茅e par Caitlin Cronin et des rencontres avec des investisseurs. Une retransmission en direct de la pr茅sentation sera disponible.
InMode (NASDAQ:INMD), ein weltweit f眉hrender Anbieter innovativer Medizintechnologien, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im August 2025 angek眉ndigt. Das Unternehmen wird am 10. j盲hrlichen Needham Virtual MedTech & Diagnostics Conference am 11. August teilnehmen, bei dem CEO Moshe Mizrahy virtuelle Einzelgespr盲che f眉hren wird.
Zus盲tzlich wird CFO Yair Malca am 45. Canaccord Annual Global Growth Conference in Boston am 12. August um 14:30 Uhr ET teilnehmen, mit einem moderierten Gespr盲ch unter der Leitung von Caitlin Cronin und Investorengespr盲chen. Eine Live-Webcast der Pr盲sentation wird verf眉gbar sein.
- None.
- None.
YOKNEAM,
10th Annual Needham Virtual MedTech & Diagnostics Conference
Presenters: Moshe Mizrahy, Chief Executive Officer
Format:听Virtual one-on-one meetings
When:听Monday, Aug. 11
听
Canaccord 45th Annual Global Growth Conference
Presenters:听Yair Malca, Chief Financial Officer
Format:听In-person fireside chat moderated by Caitlin Cronin, Director of MedTech Equity Research, and meetings
When:听Tuesday, Aug. 12 at 2:30 pm ET
A live webcast of the presentation can be accessed
Location:
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit .
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2025 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 04, 2025, and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content:
SOURCE InMode Ltd.
FAQ
When is InMode (INMD) presenting at the Canaccord Global Growth Conference 2025?
Who will represent InMode at the Needham Virtual MedTech Conference 2025?
How can investors access InMode's presentation at the Canaccord Conference?
What type of session will InMode have at the Canaccord Conference 2025?
